Mark Cuban Value Plus Drug Firm (MCCPDC) is partnering with most cancers care help firm OncoPower to supply pharmaceuticals at a decreased price by way of a platform dubbed Remedy Financial savings Suite.
The suite might be built-in inside OncoPower’s Capsule Reminder Device, which is able to alert sufferers of cheaper generic treatment choices obtainable by means of MCCPDC when sufferers log a brand new treatment into the instrument.
OncoPower provides oncology sufferers counseling, most cancers neighborhood help teams, academic movies, entry to specialists and knowledge on scientific trials.
“We’re excited to work with OncoPower to deliver decrease prescription drug costs to customers,” Alex Oshmyansky, CEO of Mark Cuban Value Plus Drug Firm, mentioned in a press release. “Value Plus Medication and OncoPower share a standard purpose of offering customers the bottom attainable value for his or her prescription treatment. With Value Plus Medication, customers will be assured they’re getting a good value and the comfort of treatment mailed on to their properties.”
THE LARGER TREND
Earlier this month, MCCPDC introduced a partnership with pharmacy profit supervisor RxPreferred Benefits, marking the corporate’s third PBM collaboration. The corporate beforehand partnered with EmsanaRx and Rightway.
“We’re engaged on including partnerships with PBMs that share our mission of cost-plus pricing, transparency and no rebates. RxPreferred will assist us prolong our mission,” Mark Cuban informed MobiHealthNews in an e mail in December.
In October, Texas-based MCCPDC introduced its first health plan partnership with Capital Blue Cross, which permits Capital members and neighborhood organizers to entry lower-cost medication by way of MCCPDC’s platform.
